Liquidia Corp LQDA

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $68.61
Market Cap $6.10B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑1,031.2% YoY
$158.32M
3-Yr CAGR: 115.0%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑59.3% YoY
-$40.02M
FCF Yield: -0.66%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (LQDA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $8.1M $6.7M 0.00% $-48.3M $-50.1M
FY 2020 $0.7M -90.8% $0.7M 0.00% $-54.1M $-54.9M -9.5%
FY 2021 $12.9M +1,637.8% $9.8M 0.00% $-34.0M $-34.1M +37.8%
FY 2022 $15.9M +24.0% $13.1M 0.00% $-28.6M $-29.2M +14.5%
FY 2023 $17.5M +9.7% $11.2M 0.00% $-41.6M $-42.9M -46.9%
FY 2024 $14.0M -20.0% $1.5M 0.00% $-93.4M $-98.4M -129.5%
FY 2025 $158.3M +1,031.2% $134.1M 0.00% $-35.7M $-40.0M +59.3%
$

Valuation

Market Price $68.61
Market Cap $6.10B
Enterprise Value $6.04B
P/E Ratio N/A
P/B Ratio 136.35
FCF Yield -0.66%
Dividend Yield N/A
Shares Outstanding 88,928,100
%

Profitability & Margins

Gross Margin 84.73%
Operating Margin -32.45%
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.48x
Revenue 3-Yr CAGR 114.98%
🛡️

Financial Health & Liquidity

Current Ratio 9.91
Cash Ratio 391.54
Debt / Equity 2.971
Debt / Assets 0.405
Cash & Equivalents $190.68M
Total Debt $132.94M
Book Value / Share $0.50
💧

Cash Flow Efficiency

Operating Cash Flow -$35.69M
Capital Expenditures (CapEx) $4.34M
Free Cash Flow -$40.02M
OCF / Revenue -22.54%
FCF / Revenue -25.28%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.50
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $327.93M
Total Liabilities $283.19M
Stockholders' Equity $44.75M
Current Assets $4.83M
Current Liabilities $487.00K